High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The endocrine hallmark of polycystic ovary syndrome (PCOS) is hyperinsulinaemic hyperandrogenism; another facet of PCOS is low-grade inflammation. METHODS: In adolescents and young women with hyperinsulinaemic hyperandrogenism (n = 118; mean age 16 years, body mass index 22 kg/m(2)), we analysed whether the PCOS-associated rise in leukocyte count is already detectable at young age and, if so, whether such elevation is lowered by metformin, flutamide-metformin, oral contraception (OC), or their combination. RESULTS: Leukocyte count (x 1000/mm(3)) in patients was high versus controls (7.5 +/- 0.1 versus 6.4 +/- 0.1; P < 0.001) due to a rise in neutrophils (4.2 +/- 0.1 versus 3.0 +/- 0.1; P < 0.001). Randomized studies at mean ages of 12.5 years (n = 24) and 15.2 years (n = 33) demonstrated normalizing effects of metformin (850 mg/day; P < 0.001) and, respectively, metformin plus flutamide (62.5 mg/day) on neutrophil counts; in young women (18.3 years; n = 41), the neutrophil count rose further on OC monotherapy (P = 0.003), but normalized on the same OC plus flutamide-metformin (P < 0.001 versus OC alone). CONCLUSIONS: (i) A high leukocyte count is already present in girls with hyperinsulinaemic hyperandrogenism, and this is due to a raised neutrophil count; (ii) this hyperneutrophilia is attenuated by metformin or flutamide-metformin, and is amplified by OC monotherapy; (iii) if these treatments are combined, the normalizing effect of flutamide-metformin overcomes the OC effect on neutrophil count.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 2×
“Recently, there has been a remarkable increment in the recognition of inter-linkages among low-grade inflammation, insulin resistance, fat excess and endothelial dysfunction in PCOS and other hyperinsulinaemic states (Libby, 2002; Ferna ´ndez-Real and Ricart, 2003; Goldfine and Kahn, 2003; Weisberg et al., 2003; Xu et…”
BackgroundInsulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Low grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624 · cited 2×
“Common exclusion criteria were: evidence for thyroid dysfunction, Cushing syndrome or hyperprolactinaemia; glucose intolerance (Expert Committe on the Diagnosis and Classification of Diabetes Mellitus, 1997), family or personal history of diabetes mellitus; late-onset congenital adrenal hyperplasia (New et al., 1983;…”
BackgroundGambineri, A., Pelusi, C., Genghini, S., Morselli‐Labate, A. M., Cacciari, M., Pagotto, U., & Pasquali, R. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.01973.x · Cited by 216 · cited 2×
“…et al., 1998; Diamanti-Kandarakis et al., 1998, 2003; Ibáñez et al., 2000a,b, 2001b, 2002a, 2003, 2004a,b; Moghetti et al., 2000; Elter et al., 2002; Ibáñez and de Zegher, 2003, 2004a, b, 2005; Morin-Papunen et al., 2003b; Gambineri et al., 2004; Guido et al., 2004; Palep-Singh et al., 2004).”
MethodIbáñez, L., Potau, N., Zampolli, M., RiquÉ, S., Saenger, P., & Carrascosa, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4084 · Cited by 199 · cited 3×
“84 mIU/ml (Ibáñez et al., 1997; Vidal-Puig and Moller, 1997); (iii) excessive 17-hydroxyprogesterone (17-OHP) response (.”
BackgroundSensitization to Insulin Induces Ovulation in Nonobese Adolescents with Anovulatory Hyperandrogenism
Ibáñez, L., Valls, C., Ferrer, A., Marcos, M. V., Rodriguez-Hierro, F., & de Zegher, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7756 · Cited by 162 · cited 1×
“…Catalan girls); (iii) history of precocious pubarche [presence of pubic hair before the age of 8 years (Ibáñez et al., 2004a,c), because the combination of these criteria is known to confer a high risk for progression to full-spectrum PCOS in adolescence (Ibáñez et al., 1998, 2001a, 2004a,c).”
BackgroundSelf-citationIbáñez, L., Ong, K., Ferrer, A., Amin, R., Dunger, D., & de Zegher, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-022002 · Cited by 100 · cited 9×
“…body adiposity of PCOS toward normal, and that may therefore improve the long-term prognosis of women with PCOS (Ibáñez and de Zegher, 2003, 2004a; Ibáñez et al., 2003a); low-dose flutamide does not appear to be hepatotoxic (Ibáñez et al., 2005); both metformin and flutamide play a…”
BackgroundMethodResultSelf-citation
Cited by
Ibáñez, L., Ong, K., Dunger, D. B., & de Zegher, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2778 · Cited by 544
Self-citationPalomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Androgen-Induced Immunosuppression
Gubbels Bupp, M. R., & Jorgensen, T. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00794 · Cited by 390
Sex hormone signaling and regulation of immune function
Hoffmann, J. P., Liu, J. A., Seddu, K., & Klein, S. L. (2023) · Immunity · doi:10.1016/j.immuni.2023.10.008 · Cited by 344
The role of low-grade inflammation in the polycystic ovary syndrome
Repaci, A., Gambineri, A., & Pasquali, R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.08.002 · Cited by 298
Metadata
- Authors
- Ibáñez, L., Jaramillo, A. M., Ferrer, A., & de Zegher, F.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-19
- Volume
- 20
- Issue
- 9
- Pages
- 2457-2462
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2138565228
- Cited by
- 94
- References
- 8
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.